Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;31(7):2129-2138.
doi: 10.1111/odi.15235. Epub 2024 Dec 30.

Non-smoking and Non-drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours

Affiliations

Non-smoking and Non-drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours

Pepijn J P van der Aa et al. Oral Dis. 2025 Jul.

Abstract

Objectives: This study aimed to explore differences in demographics, tumour characteristics and outcomes in oral squamous cell carcinoma (OSCC) patients with a history of non-smoking, non-drinking (NSND) versus smoking and/or drinking (SD).

Materials and methods: Newly diagnosed OSCC patients undergoing curative surgical treatment were prospectively included in OncoLifeS, a data biobank. Cox regression analysis was performed yielding hazard ratios (HRs) and 95% confidence intervals (95%CIs).

Results: 185 patients were included, and 32.4% of patients were NSND; this group represented an older (69 vs. 64.4 years, p < 0.01) and more female-dominated (66.7% vs. 44.5%, p = 0.02) population. NSND patients had more tongue tumours (68.3% vs. 46.4%, p < 0.01) and few floor-of-mouth tumours (1.7% vs. 20.0%, p < 0.01). Locoregional recurrence, overall survival and disease-specific survival risk were similar between the NSND and SD patients. NSND patients had a higher second primary tumour risk compared to SD patients in the multivariable analysis (adjusted HR 3.92, 1.23-12.48, p = 0.02).

Conclusion: NSND patients with OSCC have a distinct clinicopathological profile compared to SD patients, with a higher risk of second primary tumours after treatment. These differences in risk profiles should be considered in future OSCC management strategies.

Keywords: alcohol; clinicopathological features; oral cancer; recurrence; second primary tumour; smoking.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(A) Kaplan–Meier overall survival plot for NSND patients (N = 60) compared to SD patients (N = 125), log‐rank p = 0.50. (B) Kaplan–Meier disease‐specific survival plot for NSND patients (N = 60) compared to SD patients (N = 125), log‐rank p = 0.47. (C) Kaplan–Meier recurrence plot for NSND patients (N = 60) compared to SD patients (N = 125), log‐rank p = 0.42. (D) Kaplan–Meier second event plot for NSND patients (N = 60) compared to SD patients (N = 125), log‐rank p = 0.10. (E) Kaplan–Meier second primary tumour plot for NSND patients (N = 60) compared to SD patients (N = 125), log‐rank p = 0.04.

References

    1. Adeoye, J. , Tan J. Y., Ip C. M., Choi S. W., and Thomson P.. 2021. “Fact or Fiction?: Oral Cavity Cancer in Nonsmoking, Nonalcohol Drinking Patients as a Distinct Entity—Scoping Review.” Head and Neck 43, no. 11: 3662–3680. - PubMed
    1. Amin, M. B. M. D. , Edge S. B., and Greene F. L.. 2017. AJCC Cancer Staging Manual (Eight). New York, NY: Springer.
    1. Bao, X. , Liu F., Chen Q., et al. 2020. “Propensity Score Analysis Exploring the Impact of Smoking and Drinking on the Prognosis of Patients With Oral Cancer.” Head & Neck 42, no. 8: 1837–1847. - PubMed
    1. Braakhuis, B. J. , Leemans C. R., and Visser O.. 2014. “Incidence and Survival Trends of Head and Neck Squamous Cell Carcinoma in The Netherlands Between 1989 and 2011.” Oral Oncology 50, no. 7: 670–675. - PubMed
    1. Braakhuis, B. J. , Tabor M. P., Leemans C. R., van der Waal I., Snow G. B., and Brakenhoff R. H.. 2002. “Second Primary Tumors and Field Cancerization in Oral and Oropharyngeal Cancer: Molecular Techniques Provide New Insights and Definitions.” Head & Neck 24, no. 2: 198–206. - PubMed

MeSH terms